Archvest Wealth Advisors, Inc. Eli Lilly & CO Transaction History
Archvest Wealth Advisors, Inc.
- $120 Million
- Q1 2025
A detailed history of Archvest Wealth Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Archvest Wealth Advisors, Inc. holds 2,134 shares of LLY stock, worth $1.8 Million. This represents 1.47% of its overall portfolio holdings.
Number of Shares
2,134
Previous 2,106
1.33%
Holding current value
$1.8 Million
Previous $1.63 Million
8.43%
% of portfolio
1.47%
Previous 1.18%
Shares
4 transactions
Others Institutions Holding LLY
# of Institutions
4,451Shares Held
781MCall Options Held
16.5MPut Options Held
12.2M-
Lilly Endowment Inc Indianapolis, IN96MShares$81.2 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA80.4MShares$68 Billion1.05% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$55.7 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$43.4 Billion26.07% of portfolio
-
State Street Corp Boston, MA34.5MShares$29.2 Billion1.04% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $804B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...